Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 573,989 |
|
|||||
| News | - | ||||||
| Day High | 48.23 | Low High |
|||||
| Day Low | 46.51 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Janux Therapeutics Inc | JANX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.29 | 0.62% | 47.39 | 23:00:13 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 47.08 | 46.51 | 48.23 | 47.39 | 47.10 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 10,386 | 573,989 | US$ 47.38 | US$ 27,195,057 | - | 5.65 - 58.6936 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:30:14 | 1 | US$ 47.50 | USD |
Janux Therapeutics (JANX) Options Flow Summary
Janux Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.45B | 51.66M | - | 8.08M | -58.29M | -1.13 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Janux Therapeutics News
| Date | Time | Source | News Article |
|---|---|---|---|
| 3/08/2024 | 15:47 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee.. |
| 3/08/2024 | 15:23 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
| 3/08/2024 | 15:11 | Edgar (US Regulatory) | Form 8-K - Current report |
| 3/08/2024 | 15:01 | Business Wire | Janux Therapeutics Reports Fourth Quarter and Full Year 2023.. |
| 2/29/2024 | 16:30 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 2/29/2024 | 16:11 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/29/2024 | 00:22 | Business Wire | Janux Therapeutics Announces Pricing of $296.5 Million.. |
| 2/28/2024 | 20:55 | Edgar (US Regulatory) | Form FWP - Filing under Securities Act Rules 163/433 of free.. |
| 2/28/2024 | 16:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/27/2024 | 20:50 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 2/27/2024 | 16:23 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/27/2024 | 16:00 | Business Wire | Janux Therapeutics Announces Proposed Public Offering of.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical JANX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 48.60 | 50.42 | 44.71 | 48.64 | 726,097 | -1.21 | -2.49% |
| 1 Month | 37.62 | 56.27 | 34.63 | 46.81 | 867,245 | 9.77 | 25.97% |
| 3 Months | 8.29 | 58.6936 | 7.79 | 44.20 | 1,004,288 | 39.10 | 471.65% |
| 6 Months | 6.16 | 58.6936 | 5.65 | 40.05 | 527,957 | 41.23 | 669.32% |
| 1 Year | 14.66 | 58.6936 | 5.65 | 34.94 | 319,631 | 32.73 | 223.26% |
| 3 Years | 34.00 | 58.6936 | 5.65 | 28.92 | 186,576 | 13.39 | 39.38% |
| 5 Years | 34.00 | 58.6936 | 5.65 | 28.92 | 186,576 | 13.39 | 39.38% |
Janux Therapeutics Description
| Janux Therapeutics Inc is an innovative biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to better treat patients suffering from cancer. |
